High-Throughput Bioanalysis of Bevacizumab in Human Plasma Based on Enzyme-Linked Aptamer Assay Using Anti-Idiotype DNA Aptamer.
Journal
Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536
Informations de publication
Date de publication:
19 02 2019
19 02 2019
Historique:
pubmed:
23
1
2019
medline:
15
8
2020
entrez:
23
1
2019
Statut:
ppublish
Résumé
We propose a highly selective, sensitive, accurate, and high-throughput bioanalysis method for bevacizumab utilizing an anti-idiotype DNA aptamer. With this method, bevacizumab in a plasma sample was reacted in a 96-well plate immobilized with the aptamer and further reacted with a protein A-HRP conjugate. The resulting HRP activity was colorimetrically detected using a microplate reader. The calibration curve of bevacizumab ranged from 0.05 to 5.0 μg/mL, and showed a good correlation coefficient ( r
Identifiants
pubmed: 30667211
doi: 10.1021/acs.analchem.8b05725
doi:
Substances chimiques
Aptamers, Nucleotide
0
Staphylococcal Protein A
0
Bevacizumab
2S9ZZM9Q9V
Horseradish Peroxidase
EC 1.11.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM